Acro Biomedical Co Stock Analysis
| ACBM Stock | USD 0 0.00 0.00% |
ACRO Biomedical Co is overvalued with Real Value of 8.4E-4 and Hype Value of 0.001. The main objective of ACRO Biomedical pink sheet analysis is to determine its intrinsic value, which is an estimate of what ACRO Biomedical Co is worth, separate from its market price. There are two main types of ACRO Biomedical's stock analysis: fundamental analysis and technical analysis.
The ACRO Biomedical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
ACRO |
ACRO Pink Sheet Analysis Notes
About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.2. ACRO Biomedical had not issued any dividends in recent years. The entity had 3:1 split on the 22nd of May 2017. Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for ACRO Biomedical Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on ACRO Biomedical Co please contact PaoChi Chu at 317 286 6788 or go to https://acrobiomedicalco.com.ACRO Biomedical Investment Alerts
| ACRO Biomedical generated a negative expected return over the last 90 days | |
| ACRO Biomedical has some characteristics of a very speculative penny stock | |
| ACRO Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| About 50.0% of the company shares are held by company insiders |
ACRO Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 209.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ACRO Biomedical's market, we take the total number of its shares issued and multiply it by ACRO Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
ACRO Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.ACRO Biomedical Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ACRO Biomedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ACRO Biomedical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
ACRO Biomedical Outstanding Bonds
ACRO Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ACRO Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ACRO bonds can be classified according to their maturity, which is the date when ACRO Biomedical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
About ACRO Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how ACRO Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ACRO shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as ACRO Biomedical. By using and applying ACRO Pink Sheet analysis, traders can create a robust methodology for identifying ACRO entry and exit points for their positions.
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding ACRO Biomedical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Other Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.